Although less common, inactive AREs have been demonstrated, even in the presence of AR binding, and more complex mechanisms have been suggested to be involved in the regulation of genes nearby these AREs in prostate cancer cells [36, 37]. This evidence concerns the gene AR and prostate carcinoma.